Glass House Brands (GLAS) Non-Current Assets (2020 - 2026)

Glass House Brands' (GLAS) quarterly Non-Current Assets came in at $251.0 million in Q1 2026, up 3.27% year-on-year from $243.0 million in Q1 2025, and up 3370.7% on a QoQ basis from $7.2 million in Q4 2025.

Glass House Brands (GLAS) Non-Current Assets (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Non-Current Assets data on file, last reported at $251.0 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 3.27% year-over-year to $251.0 million in Q1 2026; TTM through Mar 2026 was $987.6 million, a 0.74% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, up 66.91% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $251.0 million, up from $7.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for GLAS reached as high as $304.3 million in Q3 2022 and fell as low as $2.4 million in Q4 2022.
  • Historically, Non-Current Assets has averaged $200.1 million across 5 years, with a median of $248.1 million in 2025.
  • Across the five-year window, Non-Current Assets jumped 430.62% in 2022 and retreated 12.96% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $2.4 million in 2022, then jumped by 78.8% to $4.2 million in 2023, then advanced by 2.78% to $4.3 million in 2024, then jumped by 66.91% to $7.2 million in 2025, then surged by 3370.7% to $251.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $251.0 million in Q1 2026, $7.2 million in Q4 2025, and $245.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 26.33 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 3.84 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 18.82 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 9.64 Bn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 251.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 251.00 Mn
Dec 31, 2025 7.23 Mn
Sep 30, 2025 245.48 Mn
Jun 30, 2025 248.06 Mn
Mar 31, 2025 243.04 Mn
Dec 31, 2024 4.33 Mn
Sep 30, 2024 245.40 Mn
Jun 30, 2024 253.38 Mn
Mar 31, 2024 253.17 Mn
Dec 31, 2023 4.22 Mn
Sep 30, 2023 281.93 Mn
Jun 30, 2023 277.30 Mn
Mar 31, 2023 286.84 Mn
Dec 31, 2022 2.36 Mn
Sep 30, 2022 304.29 Mn
Jun 30, 2022 262.50 Mn
Mar 31, 2022 230.59 Mn
Dec 31, 2021 -62.91 Mn
Sep 30, 2021 208.06 Mn
Jun 30, 2021 49.47 Mn